Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer.
Saved in:
| Title: | Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer. |
|---|---|
| Authors: | Qadri F; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA., Afghan MK; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA., Lutfi A; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA., Javaid S; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA., Guniganti P; Department of Radiology, New York Presbyterian/Weill Cornell Medicine, New York, NY, USA., Cardenes H; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA., Pigazzi A; Department of Surgery, Weill Cornell Medicine, New York, NY, USA., Kasi PM; Oncology and Therapeutics Research, City of Hope Orange County, Irvine, California, 92618, USA. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2026 Mar 19; Vol. 18, pp. 17588359261432049. Date of Electronic Publication: 2026 Mar 19 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359261432049 |
